# SLC12A5

## Overview
The SLC12A5 gene encodes the potassium-chloride cotransporter protein KCC2, which is a member of the solute carrier family 12. KCC2 is a transmembrane protein predominantly expressed in neurons of the central nervous system, where it plays a crucial role in maintaining low intracellular chloride concentrations. This function is essential for the proper inhibitory action of neurotransmitters such as GABA and glycine, which rely on chloride ion gradients to mediate hyperpolarizing postsynaptic potentials. The regulation of KCC2 activity is complex, involving various posttranslational modifications and interactions with other proteins, which are critical for its localization and function. Mutations in the SLC12A5 gene have been linked to several neurological disorders, including epilepsy and autism spectrum disorder, highlighting its significance in neuronal excitability and brain function (Stödberg2015Mutations; Blaesse2009CationChloride; Fukuda2019Pathogenic).

## Structure
The SLC12A5 gene encodes the KCC2 protein, a potassium-chloride cotransporter crucial for neuronal function. KCC2 is composed of 12 transmembrane domains with intracellular N- and C-termini, which are important for its regulatory functions (Stödberg2015Mutations; Fukuda2019Pathogenic). The protein exists in both monomeric and oligomeric forms, with age-dependent variations in these forms (Stödberg2015Mutations; Fukuda2019Pathogenic). 

The C-terminal domain (CTD) of KCC2 is involved in posttranslational regulation, affecting membrane trafficking and stability, and is crucial for its function (Järvelä2024A; Merner2015Regulatory). This domain contains multiple phosphorylation sites, such as S940, T934, and S937, which enhance KCC2 activity, while phosphorylation at T906 and T1007 inhibits it (Fukuda2019Pathogenic). 

KCC2 undergoes various posttranslational modifications, including glycosylation and phosphorylation, which are essential for its function and surface expression (Stödberg2015Mutations). The protein has two neuron-specific isoforms, KCC2a and KCC2b, produced through alternative promoters and first exons. KCC2b is predominant during postnatal development, while KCC2a is essential for neonatal respiratory neural networks (Fukuda2019Pathogenic).

## Function
The SLC12A5 gene encodes the potassium-chloride cotransporter KCC2, which is primarily expressed in neurons of the central nervous system. KCC2 plays a critical role in maintaining low intracellular chloride concentrations, which is essential for the proper function of inhibitory neurotransmission mediated by GABA_A and glycine receptors. By extruding chloride ions from neurons, KCC2 helps establish the electrochemical gradient necessary for hyperpolarizing postsynaptic inhibition, thus influencing neuronal excitability and network activity (Medina2014Current; Blaesse2009CationChloride).

KCC2 is developmentally regulated, with its expression increasing as neurons mature. This upregulation is crucial for the shift from depolarizing to hyperpolarizing GABA responses during neuronal development, which is important for the maturation of inhibitory synaptic transmission (Rivera1999The). KCC2 is located in the plasma membrane of neuronal somata and dendrites, where it also contributes to spine formation independent of its ion transport function (Blaesse2009CationChloride).

The activity of KCC2 is regulated by various mechanisms, including phosphorylation by kinases such as SPAK/OSR1, which can inhibit its function. This regulation is vital for controlling the chloride gradient across the neuronal membrane, affecting the balance of excitatory and inhibitory signals in neurons (Medina2014Current).

## Clinical Significance
Mutations in the SLC12A5 gene, which encodes the KCC2 protein, are associated with several neurological disorders. These mutations can lead to impaired chloride extrusion, resulting in increased neuronal excitability and contributing to conditions such as epilepsy, autism spectrum disorder (ASD), and schizophrenia (Järvelä2024A; Fukuda2019Pathogenic). Specifically, loss-of-function mutations in SLC12A5 are linked to epilepsy of infancy with migrating focal seizures (EIMFS), a severe form of early-onset epilepsy characterized by migrating focal seizures and developmental delays (Stödberg2015Mutations; Saitsu2016Impaired).

Heterozygous missense mutations, such as R952H and R1049C, have been associated with idiopathic generalized epilepsy and febrile seizures, affecting the KCC2 cytoplasmic C-terminus and reducing chloride extrusion (Stödberg2015Mutations; Fukuda2019Pathogenic). These mutations also show decreased phosphorylation, which is crucial for KCC2 function (Merner2015Regulatory).

In addition to epilepsy, SLC12A5 variants have been implicated in ASD and schizophrenia, with studies suggesting that these mutations may disrupt GABAergic signaling, contributing to the pathogenesis of these disorders (Merner2015Regulatory). The gene's role in maintaining neuronal chloride homeostasis underscores its importance in neurodevelopmental and psychiatric conditions.

## Interactions
The SLC12A5 gene encodes the KCC2 protein, a potassium-chloride cotransporter primarily expressed in neurons. KCC2 interacts with various proteins that influence its function and localization. One significant interaction is with the cytoskeletal protein 4.1N, which affects KCC2's membrane localization and function. This interaction is crucial for maintaining the proper positioning of KCC2 on the neuronal membrane, which is essential for its role in chloride ion transport (Hebert2004Molecular).

KCC2 is also regulated by interactions with WNK kinases, which modulate its activity through phosphorylation. This regulatory mechanism is vital for maintaining neuronal chloride homeostasis, as phosphorylation can either enhance or inhibit KCC2's transport activity. Specific phosphorylation sites on KCC2, such as S940, T934, and S937, are known to enhance its activity, while others like T906 and T1007 inhibit it. The WNK1-SPAK/OSR1 kinase pathway plays a significant role in this modulation, particularly during neuronal development, affecting GABA-mediated neurotransmission (Fukuda2019Pathogenic).

These interactions highlight the complex regulatory network that controls KCC2 function, ensuring proper neuronal excitability and chloride ion balance, which are critical for normal brain function and development.


## References


[1. (Medina2014Current) Igor Medina, Perrine Friedel, Claudio Rivera, Kristopher T. Kahle, Nazim Kourdougli, Pavel Uvarov, and Christophe Pellegrino. Current view on the functional regulation of the neuronal k+-cl− cotransporter kcc2. Frontiers in Cellular Neuroscience, 2014. URL: http://dx.doi.org/10.3389/fncel.2014.00027, doi:10.3389/fncel.2014.00027. This article has 146 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fncel.2014.00027)

[2. (Rivera1999The) Claudio Rivera, Juha Voipio, John A. Payne, Eva Ruusuvuori, Hannele Lahtinen, Karri Lamsa, Ulla Pirvola, Mart Saarma, and Kai Kaila. The k+/cl− co-transporter kcc2 renders gaba hyperpolarizing during neuronal maturation. Nature, 397(6716):251–255, January 1999. URL: http://dx.doi.org/10.1038/16697, doi:10.1038/16697. This article has 1708 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/16697)

[3. (Merner2015Regulatory) Nancy D. Merner, Madison R. Chandler, Cynthia Bourassa, Bo Liang, Arjun R. Khanna, Patrick Dion, Guy A. Rouleau, and Kristopher T. Kahle. Regulatory domain or cpg site variation in slc12a5, encoding the chloride transporter kcc2, in human autism and schizophrenia. Frontiers in Cellular Neuroscience, October 2015. URL: http://dx.doi.org/10.3389/fncel.2015.00386, doi:10.3389/fncel.2015.00386. This article has 86 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fncel.2015.00386)

[4. (Fukuda2019Pathogenic) Atsuo Fukuda and Miho Watanabe. Pathogenic potential of human slc12a5 variants causing kcc2 dysfunction. Brain Research, 1710:1–7, May 2019. URL: http://dx.doi.org/10.1016/j.brainres.2018.12.025, doi:10.1016/j.brainres.2018.12.025. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.brainres.2018.12.025)

[5. (Stödberg2015Mutations) Tommy Stödberg, Amy McTague, Arnaud J. Ruiz, Hiromi Hirata, Juan Zhen, Philip Long, Irene Farabella, Esther Meyer, Atsuo Kawahara, Grace Vassallo, Stavros M. Stivaros, Magnus K. Bjursell, Henrik Stranneheim, Stephanie Tigerschiöld, Bengt Persson, Iftikhar Bangash, Krishna Das, Deborah Hughes, Nicole Lesko, Joakim Lundeberg, Rod C. Scott, Annapurna Poduri, Ingrid E. Scheffer, Holly Smith, Paul Gissen, Stephanie Schorge, Maarten E. A. Reith, Maya Topf, Dimitri M. Kullmann, Robert J. Harvey, Anna Wedell, and Manju A. Kurian. Mutations in slc12a5 in epilepsy of infancy with migrating focal seizures. Nature Communications, September 2015. URL: http://dx.doi.org/10.1038/ncomms9038, doi:10.1038/ncomms9038. This article has 141 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms9038)

[6. (Hebert2004Molecular) Steven C. Hebert, David B. Mount, and Gerardo Gamba. Molecular physiology of cation-coupled cl? cotransport: the slc12 family. Pfl�gers Archiv European Journal of Physiology, 447(5):580–593, February 2004. URL: http://dx.doi.org/10.1007/s00424-003-1066-3, doi:10.1007/s00424-003-1066-3. This article has 221 citations.](https://doi.org/10.1007/s00424-003-1066-3)

[7. (Järvelä2024A) Viivi Järvelä, Mira Hamze, Jonna Komulainen-Ebrahim, Elisa Rahikkala, Johanna Piispala, Mika Kallio, Salla M. Kangas, Tereza Nickl, Marko Huttula, Reetta Hinttala, Johanna Uusimaa, Igor Medina, and Esa-Ville Immonen. A novel pathogenic slc12a5 missense variant in epilepsy of infancy with migrating focal seizures causes impaired kcc2 chloride extrusion. Frontiers in Molecular Neuroscience, April 2024. URL: http://dx.doi.org/10.3389/fnmol.2024.1372662, doi:10.3389/fnmol.2024.1372662. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2024.1372662)

[8. (Blaesse2009CationChloride) Peter Blaesse, Matti S. Airaksinen, Claudio Rivera, and Kai Kaila. Cation-chloride cotransporters and neuronal function. Neuron, 61(6):820–838, March 2009. URL: http://dx.doi.org/10.1016/j.neuron.2009.03.003, doi:10.1016/j.neuron.2009.03.003. This article has 604 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuron.2009.03.003)

[9. (Saitsu2016Impaired) Hirotomo Saitsu, Miho Watanabe, Tenpei Akita, Chihiro Ohba, Kenji Sugai, Winnie Peitee Ong, Hideaki Shiraishi, Shota Yuasa, Hiroshi Matsumoto, Khoo Teik Beng, Shinji Saitoh, Satoko Miyatake, Mitsuko Nakashima, Noriko Miyake, Mitsuhiro Kato, Atsuo Fukuda, and Naomichi Matsumoto. Impaired neuronal kcc2 function by biallelic slc12a5 mutations in migrating focal seizures and severe developmental delay. Scientific Reports, July 2016. URL: http://dx.doi.org/10.1038/srep30072, doi:10.1038/srep30072. This article has 85 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep30072)